ZIMMER BIOMET HOLDINGS, INC. - 8-K Filing

This Form 8-K details the events of Zimmer Biomet Holdings, Inc.’s annual shareholder meeting held on May 22, 2026. Shareholders elected ten directors for one-year terms, ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026, and approved, on an advisory basis, the compensation of the named executive officers. However, a shareholder proposal seeking an Independent Board Chairman was rejected. The filing also lists the company’s registered securities, including common stock and various notes due in 2026, 2027, and 2032, all traded on the New York Stock Exchange. The report includes detailed vote tabulation for each proposal, showing the number of For, Against, Abstain, and Broker Non-Votes. The company also confirmed the exhibits included in the filing, such as the Cover Page Interactive Data File.